Neurological drugs developer Karuna Therapeutics is building up its pipeline with a pair of molecules initially developed for kidney disorders. It’s a small bet that could pay off in a big way by ...
Clinical stage biopharma firm Karuna Therapeutics has named Bill Meury president and CEO, a move effective on January 3. He succeeds Dr. Steve Paul, who is transitioning to chief scientific officer ...
Karuna Health, a virtual health communications platform, has been acquired by the healthcare software company Commure, according to a Substack post from Karuna’s CEO and cofounder Joe Kahn. Through ...
In an age where violence is increasingly associated with children, efforts are being made to instill some 'Karuna' among them. NAGPUR: In an age where violence is increasingly associated with children ...
Following the assassination of his protégé, Rajan Sathiamoorthy, and the digging up of his body by men sent by LTTE supremo Velupillai Prabhakaran, the rebel LTTE leader Col. Karuna has commenced a ...
Royalty Pharma announced Thursday morning that it has acquired an interest in PureTech Health’s royalty in Karuna Therapeutics’ schizophrenia treatment KarXT for up to $500 million. As per the terms ...
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (“Karuna,” formerly Karuna Pharmaceuticals), focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results